Eagle Veterinary Technology Co.Ltd
Eagle Veterinary Technology Co.,Ltd manufactures and sells animal health care products in South Korea. The company offers antibiotics, antibacterials, anthelmintics, antihistamins, and in the form of injectable, feed additives, oral liquids, and soluble powders for swine, poultry, and bovine. Eagle Veterinary Technology Co.,Ltd also exports its products to New Zealand, Australia, Vietnam, Kenya, … Read more
Eagle Veterinary Technology Co.Ltd (044960) - Total Liabilities
Latest total liabilities as of September 2025: ₩10.35 Billion KRW
Based on the latest financial reports, Eagle Veterinary Technology Co.Ltd (044960) has total liabilities worth ₩10.35 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Eagle Veterinary Technology Co.Ltd - Total Liabilities Trend (2014–2024)
This chart illustrates how Eagle Veterinary Technology Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Eagle Veterinary Technology Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Eagle Veterinary Technology Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Innometry Co. Ltd
KQ:302430
|
Korea | ₩12.58 Billion |
|
BG Container Glass Public Company Limited
BK:BGC
|
Thailand | ฿12.84 Billion |
|
DENTA
NSE:DENTA
|
India | ₹270.50 Million |
|
Embrace Change Acquisition Corp Ordinary Shares
NASDAQ:EMCG
|
USA | $6.75 Million |
|
Klimasan Klima Sanayi ve Ticaret AS
IS:KLMSN
|
Turkey | TL6.25 Billion |
|
Helport AI Limited Ordinary Shares
NASDAQ:HPAI
|
USA | $19.72 Million |
|
Suprema HQ Inc
KQ:094840
|
Korea | ₩7.21 Billion |
|
Yeh-Chiang Technology
TWO:6124
|
Taiwan | NT$1.40 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Eagle Veterinary Technology Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Eagle Veterinary Technology Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Eagle Veterinary Technology Co.Ltd (2014–2024)
The table below shows the annual total liabilities of Eagle Veterinary Technology Co.Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩12.65 Billion | -3.72% |
| 2023-12-31 | ₩13.14 Billion | +10.28% |
| 2022-12-31 | ₩11.91 Billion | +1.20% |
| 2021-12-31 | ₩11.77 Billion | +10.29% |
| 2020-12-31 | ₩10.67 Billion | +2.51% |
| 2019-12-31 | ₩10.41 Billion | -9.97% |
| 2018-12-31 | ₩11.56 Billion | -35.23% |
| 2017-12-31 | ₩17.85 Billion | +22.94% |
| 2016-12-31 | ₩14.52 Billion | +11.09% |
| 2015-12-31 | ₩13.07 Billion | +4.18% |
| 2014-12-31 | ₩12.55 Billion | -- |